KRAS and neoplasm: Apart from KRAS and PIK3CA, other genes preferentially altered in the right-sided primary tumor sites, such as PRKDC, ERBB3, BCLAF1 and NOTCH1, have been reported to be correlated with poor prognosis or migration in CRC [20–26].